Nigel P.S. Crawford
Sanofi (United States)(US)
Publications by Year
Research Areas
RNA modifications and cancer, Genetics, Bioinformatics, and Biomedical Research, Cancer-related gene regulation, Inflammatory Bowel Disease, Prostate Cancer Treatment and Research
Most-Cited Works
- → Mechanisms of metastasis(2008)294 cited
- → Bromodomain 4 activation predicts breast cancer survival(2008)189 cited
- → Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer(2012)121 cited
- → Germline polymorphisms in SIPA1are associated with metastasis and other indicators of poor prognosis in breast cancer(2006)117 cited
- → Metastasis Predictive Signature Profiles Pre-exist in Normal Tissues(2005)115 cited
- → Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers(2020)97 cited
- → Rrp1b, a New Candidate Susceptibility Gene for Breast Cancer Progression and Metastasis(2007)89 cited
- → A Systems Genetics Approach Identifies CXCL14, ITGAX, and LPCAT2 as Novel Aggressive Prostate Cancer Susceptibility Genes(2014)86 cited
- → Deletion of the Proline-Rich Region of the Murine Metastasis Susceptibility Gene Brd4 Promotes Epithelial-to-Mesenchymal Transition- and Stem Cell-Like Conversion(2011)80 cited
- → The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival(2008)72 cited